Metformin
Metformin is the most widely prescribed pill for type 2 diabetes in the world, and for good reason: it is inexpensive, has been used safely for decades, and lowers blood sugar without causing weight gain or, on its own, dangerous low blood sugar. In recent years it has also drawn intense scientific interest for a much bigger question — whether it might slow aspects of aging itself. This page explains what metformin actually does, what it is proven to treat, its side effects, and an honest look at the longevity research, which remains investigational and unproven. None of this is a substitute for your own doctor's advice; metformin is prescription-only.
Table of Contents
- What Metformin Is
- How It Works
- What It's Used For
- Benefits Beyond Blood Sugar
- Side Effects & Safety
- The Longevity & Anti-Aging Research
- Who Should Be Cautious
- Research Papers
- Connections
What Metformin Is
Metformin is an oral medication used to lower blood sugar, and it is the single most prescribed glucose-lowering drug worldwide. It belongs to a class of medicines called biguanides. Major clinical guidelines, including the American Diabetes Association's Standards of Care, recommend it as the usual first-line medication when someone with type 2 diabetes needs drug treatment.
Its roots are surprisingly old. The compound is chemically related to guanidine, a substance found in Galega officinalis — a plant known as French lilac or goat's rue — which was used in folk medicine for centuries to ease the excessive urination that we now recognize as a symptom of diabetes. Modern metformin was developed in the mid-twentieth century and has been in widespread clinical use since the 1990s in the United States (and earlier in Europe).
Today metformin is generic and very cheap — often just a few dollars a month. Combined with its long safety record, that affordability is a big part of why it remains the default starting medication for type 2 diabetes around the globe.
How It Works
The main thing metformin does is tell your liver to stop overproducing sugar. In type 2 diabetes, the liver tends to dump too much glucose into the bloodstream, especially overnight. Metformin reduces this overproduction, which is the largest single reason blood sugar comes down.
It also improves insulin sensitivity — meaning your muscles and other tissues respond better to insulin and pull more sugar out of the blood. Because metformin works by reducing excess glucose rather than by squeezing out more insulin, two important things follow:
- It does not cause weight gain (and may lead to slight weight loss), unlike some other diabetes drugs.
- By itself it does not cause hypoglycemia (dangerously low blood sugar). That risk goes up only when it is combined with insulin or certain other medications.
On a cellular level, metformin is thought to activate an energy-sensing enzyme called AMPK, which acts like a low-fuel signal that shifts cells toward conserving and using energy more efficiently. Researchers increasingly believe a meaningful part of its effect also happens in the gut — altering how the intestine handles glucose and shifting the balance of the gut microbiome (the community of bacteria living in your digestive tract). The full picture is still being worked out, which is part of why metformin remains such an actively studied drug.
What It's Used For
Metformin has one well-established use and several others supported by varying levels of evidence.
Type 2 diabetes (first-line)
This is the core, proven use. For most adults newly diagnosed with type 2 diabetes who need medication, guidelines recommend starting with metformin alongside diet and exercise.
Prediabetes and diabetes prevention
In the landmark Diabetes Prevention Program, a large U.S. trial in people with prediabetes, metformin reduced the chance of developing type 2 diabetes by about 31% compared with placebo. Importantly, an intensive lifestyle program (diet and exercise) did even better — roughly a 58% reduction, clearly outperforming the drug. So metformin can help prevent diabetes, but lifestyle change is the more powerful tool, and metformin is generally reserved for higher-risk individuals.
Polycystic ovary syndrome (PCOS)
PCOS is closely tied to insulin resistance. Because metformin improves the body's response to insulin, it is sometimes prescribed to help with PCOS-related issues such as irregular menstrual cycles and, in some cases, fertility. It is not a cure for PCOS, and its role is one part of a broader treatment plan decided with a clinician.
Gestational diabetes
In some pregnancies complicated by diabetes, metformin is used as an option to help manage blood sugar. Whether it is appropriate is an individual decision made with an obstetric and diabetes care team.
Benefits Beyond Blood Sugar
Part of metformin's enduring popularity is a set of advantages that go beyond simply lowering glucose:
- Weight-neutral or slight weight loss. Unlike several other diabetes medications, metformin does not pack on pounds and often nudges weight slightly downward — a meaningful plus for many people with type 2 diabetes.
- A favorable heart signal. In the UK Prospective Diabetes Study (UKPDS 34), overweight patients with type 2 diabetes treated with metformin had fewer diabetes-related complications and deaths than those managed with diet alone. This is one of the reasons metformin is viewed favorably, though this cardiovascular benefit comes largely from that specific subgroup in one landmark trial rather than from a long list of identical studies.
- Very low cost. As an old generic, it is one of the most affordable prescription medications available.
- A strong, decades-long safety record. Hundreds of millions of people have taken metformin, and its risks and quirks are unusually well understood.
Side Effects & Safety
Most people tolerate metformin well, but it has some characteristic side effects worth knowing about.
Stomach and gut upset (common)
The most frequent complaints are nausea, diarrhea, stomach cramping, and gas, especially in the first weeks. These are often manageable and tend to ease over time. Common strategies that doctors use to reduce them include starting at a low dose and increasing slowly, using an extended-release (slow-release) formulation, and taking it with food.
Vitamin B12 deficiency (with long-term use)
Taken over years, metformin can lower the body's absorption of vitamin B12. A randomized trial found B12 levels dropped meaningfully over several years of use. Low B12 can cause fatigue, anemia, and nerve symptoms (like numbness or tingling). This is the reason it is reasonable to have B12 levels checked periodically during long-term treatment, and to correct a deficiency if it appears.
Lactic acidosis (very rare)
The most serious potential complication is lactic acidosis — a dangerous buildup of acid in the blood. It is genuinely very rare, but it is the underlying reason metformin is avoided or temporarily paused in situations where the body can't clear the drug or is starved of oxygen, such as:
- Severe kidney disease (the kidneys clear metformin, so kidney function — measured as eGFR — guides whether the drug is used and at what dose).
- Acute illness, dehydration, or anything causing low oxygen levels.
- Around contrast imaging (certain CT/X-ray dyes) and some surgeries, where metformin is often held for a short period.
For most people with normal-to-moderate kidney function, this risk is extremely low — but it explains the precautions below.
The Longevity & Anti-Aging Research
Metformin has become one of the most talked-about drugs in aging research — but it is essential to be clear: metformin is not approved or proven as an anti-aging drug. This is an area of active investigation, not established medicine.
The interest comes from several threads. Laboratory and animal studies suggest metformin can influence pathways tied to aging (including that AMPK energy-sensing system). And some observational studies have produced an eye-catching finding: people with diabetes taking metformin sometimes appeared to live as long as or longer than people without diabetes — which is surprising, since diabetes usually shortens life. Researchers have also explored possible links to lower rates of certain cancers.
But observational data like this is hypothesis-generating, not proof. People who are prescribed and reliably take metformin may differ in many ways from those who aren't, and such studies cannot establish cause and effect. To actually test whether metformin affects aging, scientists proposed a dedicated clinical trial: TAME (Targeting Aging with Metformin), designed to see whether the drug delays the onset of age-related diseases as a group. As of this writing the central question remains unsettled — the trial has faced funding and logistical hurdles, and there is no completed, definitive human trial showing metformin extends healthy lifespan in people without diabetes.
There is also a specific reason for caution in healthy, active people. A 2019 study found that metformin blunted some of the beneficial adaptations to aerobic exercise — including improvements in fitness and muscle mitochondria — in older adults. In other words, for someone exercising to stay healthy, metformin might work against part of what they're trying to gain.
The honest bottom line: the longevity research is intriguing but investigational. Healthy people without diabetes who take metformin hoping to slow aging are acting ahead of the evidence, and they take on its real side effects (B12 loss, GI upset) for a benefit that has not been proven in humans.
Who Should Be Cautious & Talking to Your Doctor
Metformin is prescription-only, and whether it's right for you — and at what dose — is an individual medical decision. Be especially sure to talk with your doctor if any of the following apply:
- Reduced kidney function. Metformin is cleared by the kidneys, so significant kidney impairment may mean a lower dose or avoiding the drug. Your eGFR (a kidney function number from a blood test) helps guide this.
- Significant liver disease or conditions that can cause low oxygen or dehydration, which raise the rare risk of lactic acidosis.
- Upcoming contrast imaging or surgery. Tell the care team you take metformin — it is often paused around iodinated-contrast scans and certain operations and restarted once kidney function is confirmed stable.
- Long-term use. Ask about periodic vitamin B12 monitoring, especially if you develop fatigue or nerve symptoms.
Finally, because dosing must be individualized and the cautions above are real, do not self-source metformin or take someone else's prescription — including for unproven longevity purposes. Work with a clinician who can match the dose to your kidney function and overall health.
Research Papers
- UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). The Lancet, 1998;352:854–865. doi:10.1016/S0140-6736(98)07037-8 — Landmark trial linking metformin to fewer complications and deaths in overweight type 2 diabetes patients.
- Knowler WC, et al. (Diabetes Prevention Program Research Group). Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine, 2002;346:393–403. doi:10.1056/NEJMoa012512 — Metformin cut diabetes risk ~31%, but intensive lifestyle change did better (~58%).
- American Diabetes Association Professional Practice Committee. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care, 2024;47(Suppl. 1):S158–S178. doi:10.2337/dc24-S009 — Current U.S. guideline positioning metformin as a foundational first-line therapy for type 2 diabetes.
- de Jager J, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ, 2010;340:c2181. doi:10.1136/bmj.c2181 — Randomized evidence that long-term metformin progressively lowers vitamin B12 levels.
- Barzilai N, Crandall JP, Kritchevsky SB, Espeland MA. Metformin as a Tool to Target Aging. Cell Metabolism, 2016;23(6):1060–1065. doi:10.1016/j.cmet.2016.05.011 — Perspective laying out the rationale for the TAME trial; frames aging effects as a hypothesis to be tested, not established.
- Konopka AR, et al. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell, 2019;18(1):e12880. doi:10.1111/acel.12880 — Found metformin blunted exercise-induced gains in fitness and muscle mitochondria, a caution for healthy users.